Status:
TERMINATED
Does Oral Baclofen Improve Care and Comfort in Spastic Children in Nursing Homes?
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Cerebral Palsy
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Baclofen is a drug that reduces the muscle stiffness. In disabled children that have very stiff muscles, the stiffness and secondary changes in the joints may cause discomfort and pain. In this study ...
Eligibility Criteria
Inclusion
- Cerebral palsy nursing homes children ages 1-18 years spastic quadriplegia
Exclusion
- active epilepsy severe truncal hypotonia
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00752934
Start Date
October 1 2010
End Date
June 1 2015
Last Update
December 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saare Zedek Medical Center
Jerusalem, Israel